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Abstract 
Background: Point‑of‑care ultrasound is increasingly being used as a diagnostic tool in resource‑limited settings. The 
majority of existing ultrasound protocols have been developed and implemented in high‑resource settings. In sub‑
Saharan Africa (SSA), patients with heart failure of various etiologies commonly present late in the disease process, 
with a similar syndrome of dyspnea, edema and cardiomegaly on chest X‑ray. The causes of heart failure in SSA differ 
from those in high‑resource settings. Point‑of‑care ultrasound has the potential to identify the underlying etiology 
of heart failure, and lead to targeted therapy. Based on a literature review and weighted score of disease prevalence, 
diagnostic impact and difficulty in performing the ultrasound, we propose a context‑specific cardiac ultrasound pro‑
tocol to help differentiate patients presenting with heart failure in SSA.
Results: Pericardial effusion, dilated cardiomyopathy, cor pulmonale, mitral valve disease, and left ventricular 
hypertrophy were identified as target conditions for a focused ultrasound protocol in patients with cardiac failure and 
cardiomegaly in SSA. By utilizing a simplified 5‑question approach with all images obtained from the subxiphoid view, 
the protocol is suitable for use by health care professionals with limited ultrasound experience.
Conclusions: The “Cardiac ultrasound for resource‑limited settings (CURLS)” protocol is a context‑specific algorithm 
designed to aid the clinician in diagnosing the five most clinically relevant etiologies of heart failure and cardiomegaly 
in SSA. The protocol has the potential to influence treatment decisions in patients who present with clinical signs of 
heart failure in resource‑limited settings outside of the traditional referral institutions.
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Background
Point-of-care ultrasound is increasingly being used as a 
diagnostic tool in resource-limited settings. With more 
portable and affordable machines, providers from small 
clinics to large hospitals have increasing access to this 
technology. The majority of ultrasound protocols aimed 
at cardiac pathology have been developed and imple-
mented in high-resource settings where more advanced 
imaging technology is usually available to help the 
clinician confirm their ultrasound diagnosis. As cardio-
vascular disease is an increasing cause of morbidity and 
mortality in sub-Saharan Africa (SSA) [1], there is a need 
for context-specific ultrasound protocols suited to the 
needs and available resources in this setting.
In SSA, patients with heart disease often present late 
in their clinical course with signs and symptoms of 
heart failure [2]. The etiology of heart disease in this 
context falls into several categories which are difficult 
to distinguish at the end stages, including hyperten-
sion and coronary artery disease [3], as well as com-
municable diseases such as tuberculosis (TB) and 
rheumatic fever [3]. There are striking differences in 
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the epidemiology of heart diseases when comparing 
SSA with the United States or Europe [4]. Based on a 
number of studies comparing patients from SSA with 
patients from Europe, the Americas and Asia, African 
patients with heart failure are younger, more likely to 
be female and less likely to suffer from ischemic heart 
disease [4–6].
Patients with heart failure of various etiologies com-
monly present with a similar syndrome of dyspnea, 
edema and cardiomegaly on chest X-ray. In tropical set-
tings common cardiac causes of dyspnea and edema are 
dilated cardiomyopathy (e.g., peripartum or HIV-asso-
ciated cardiomyopathy), hypertensive cardiomyopathy, 
pericardial effusion with tamponade (most commonly 
due to TB), post-rheumatic heart disease (RHD) and cor 
pulmonale [7, 8]. Point-of-care ultrasound may be the 
only tool available to clinicians to help them make defini-
tive diagnoses allowing for targeted treatment.
A large body of evidence has demonstrated the feasibil-
ity and clinical utility of point-of-care cardiac ultrasound 
performed by non-cardiologists [9–13]. In SSA, stud-
ies on handheld echocardiography showed promising 
results in screening children for RHD by both cardiolo-
gists and non-experts, trained in a simplified screening 
protocol [9–11, 14, 15]. In addition, focused cardiopul-
monary ultrasound was demonstrated to improve diag-
nostic accuracy in emergency care in Ghana, particularly 
in patients with cardiac disease such as cardiogenic 
shock, congestive heart failure or acute valvular disease 
[16]. More widespread use of echocardiography in low- 
and middle-income countries beyond referral centers has 
great potential. A recent study performed in a district 
hospital in South Africa demonstrated that patient man-
agement was influenced by echocardiography in 83.8% 
of patients, who predominantly suffered from valvu-
lar heart disease [17]. A study in Rwanda demonstrated 
that trained nurses were able to accurately diagnose dif-
ferent causes of heart failure and provide care for heart 
failure patients using a simplified echocardiography pro-
tocol [18]. Similarly clinical officers in Kenya were able 
to improve their diagnosis of cardiac conditions using a 
focused protocol after an 8-h training [12]. These stud-
ies demonstrate the numerous applications and practical 
possibilities to expand the use of echocardiography in 
SSA.
As ultrasound becomes more ubiquitous, there is a 
need for context-specific training protocols. In the fol-
lowing pages, we outline a cardiac ultrasound protocol 
specifically for providers working in sub-Saharan Africa 
(SSA). This protocol is based on a literature review of 
locally prevalent conditions, and created for ease of use 
both in regards to performing ultrasound with basic 
B mode software capabilities and for teaching cardiac 
ultrasound in a way that is most relevant for healthcare 
professionals in SSA.
Methods
Literature review on prevalence of cardiac conditions
We searched PubMed with the following search string: 
“Africa” [MeSH Terms] AND “heart diseases” [MeSH 
Terms] and extracted information on the frequency of 
causes of heart failure. Our search was conducted on 1 
August 2018, and an additional search on 11 October 
2019. We limited our search to papers published in the 
last 5 years and relevant references cited herein published 
within the last 10 years. We excluded papers focusing on 
pediatric populations, ECG findings, surgery, cardiovas-
cular risk or stroke, studies outside SSA, case reports 
and studies focusing on clinical characteristics of specific 
groups, such as HIV patients or patients with congenital 
heart disease. Review papers were included to search for 
additional relevant references. Geographic area, number 
of assessed patients and relative frequencies of underly-
ing conditions were extracted. These data were subse-
quently used to identify the most relevant conditions that 
need to be assessed in a cardiac ultrasound protocol.
Weighting of cardiac ultrasound application
Given that our goal is to create a protocol that is most 
relevant for clinicians in resource-limited settings, epi-
demiology was combined with ease of use and predicted 
clinical relevance to create a scoring system that would 
identify the high-yield ultrasound applications. Each 
application was assessed on three components: dis-
ease prevalence, diagnostic impact, and ultrasound dif-
ficulty (Table  1). The weight of disease prevalence was 
based on data from our literature review. We considered 
approximate average frequencies above 15% as frequent 
(weight = 3) and below 5% as rare (weight = 1). As the 
populations under study varied in age and sex distribu-
tion, and may thus not be comparable, no overall aver-
age prevalence was calculated. Prevalence was weighted 
as 3 if the prevalence was > 15% in the majority of stud-
ies. Weighting ultrasound difficulty was based on expert 
consensus between co-authors with experience in ultra-
sound teaching in resource-limited settings (TH, DKam, 
MH, VK, BK); weight of therapeutic impact by consen-
sus of co-authors experienced in treating cardiac patients 
in clinical practice in these settings (DKah, PG, CW). 
Although the multifactorial weighting model has not 
been formally validated and the weights are partially 
subjective, the method first proposed by Van Hoving 
et al. [19] is transparent and easy to apply. Therefore, we 
consider it currently the best option to inform decisions 
about relevant curriculum content in various settings. 
The weighting of cardiac ultrasound applications allowed 
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us to generate a protocol for focused cardiac ultrasound 
in resource-limited settings (CURLS) that is based on 
the most relevant applications and prioritizes practicality 
and ease of use for non-expert sonographers.
Results
Epidemiology of heart disease in sub‑Saharan Africa
878 titles and abstracts were screened; nine papers 
provided relevant information on etiologies of car-
diac failure in SSA [20–28], nine additional papers 
were identified by reviewing references [18, 29–36]. 
Geographic distribution of the study areas of included 
studies is presented in Fig.  1, showing the wide geo-
graphic range. The literature review flowchart and 
baseline characteristics of included studies are given 
in Additional file  1: Figure S1 and Table  S1. Relative 
frequencies of the etiologies of heart failure are sum-
marized in Table  2. Hypertension was the most com-
mon cause of heart failure in all studies, except in one 
study from Djibouti where ischemic heart disease was 
the most common cause [32]. Cardiomyopathy was the 
second most common cause in most studies. Ischemic 
Table 1 Weighting of prevalence, diagnostic impact and difficulty of POCUS applications
For prevalence and impact the numbers indicate the following levels: 1 = low, 2 = medium, 3 = high. For difficulty, scoring is reversed with numbers indicating the 
following levels: 1 = high, 2 = medium, and 3 = low. This allows for a composite score where the higher numbers correspond to increasing relevance and applicability 
of POCUS
US ultrasound, TEE transesophageal echocardiography, cw continuous wave, b/w black and white
Weight Disease prevalence Diagnostic impact of US US difficulty and technical requirements
1 Rare (< 5%) Minor or no management change Technically advanced, often requiring special 
equipment like TEE probe, cw‑Doppler, 
cardiac software
2 Relatively common (5–15%) Management change Moderate, may require color‑Doppler
3 Very common (> 15%) Urgent management change (possibly life 
threatening)
Technically easy, only basic b/w US
Fig. 1 Geographic area of the 18 included studies on frequency of causes of cardiac failure. Note that some studies included multiple sites. 
Therefore, there are more study sites in the figure than included studies
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Table 2 Etiology of heart failure in sub-Saharan Africa
HF heart failure
a The majority of this group consists of idiopathic dilated cardiomyopathy. Peripartum cardiomyopathy and HIV-related cardiomyopathy were mentioned in several 
studies, while thyrotoxicosis, alcohol and diabetes were mentioned incidentally as causes for dilated cardiomyopathy
First author, year Patients 
with HF 
(n)
Hypertension 
(%)
Dilated 
cardiomyopathy 
(%)a
Ischemic 
(%)
Valvular 
(%)
Right‑sided 
HF/cor 
pulmonale 
(%)
Effusion 
(%)
Endomyocardial 
fibrosis (%)
Congenital 
(%)
Ansa, 2016 339 48.6 35.4 1.4
Appiah, 2017 1916 52.3 19.8 4 7.6 0.4
Bonsu, 2017 1488 61.2 19.9 12.9
Boombhi, 2017 148 30.2 28.6 6.4 11.9 8.7 4
Damasceno, 2012 1006 45.4 18.8 7.7 14.3 6.8 1.3
Dokainish, 2017 1294 35 14.2 20 11 0.1
Kingery, 2017 588 42.8 19.3 6.2 16.6 7.6
Kwan, 2013 192 8 54 25 1.4 0.7 5
Makubi, 2014 427 45 22.4 9 12
Massoure, 2013 45 13 7 62
Mwita, 2017 193 40.4 19.6 5.7 9.3 6.2
Nkoke, 2017 529 43.2 17.6 9.6 11.7 8.8 3.8 2.1
Ogah, 2013 452 78.5 7.5 0.4 2.4 4.4 3.3 0.9 0.4
Ojji, 2013 1515 60.6 12 0.4 9.4
Onwuchekwa, 2009 423 56.3 7.3 0.2 4.3 2.1
Pio, 2014 297 43.1 5.9 19.2 11.8 2.7 1.7 2.7
Stewart, 2008 844 33 28 9 8 27
Table 3 Ranking of cardiac ultrasound applications according to prevalence, impact and difficulty
For prevalence and impact the numbers indicate the following levels: 1 = low, 2 = medium, 3 = high. For difficulty, scoring is reversed with numbers indicating the 
following levels: 1 = high, 2 = medium, and 3 = low. For prevalence and impact the numbers indicate the following levels: 1 = low, 2 = medium, 3 = high. For difficulty 
scoring is reversed with numbers indicating the following levels: 1 = high, 2 = medium, and 3 = low. This allows for a composite score where the higher numbers 
correspond to increasing relevance and applicability of POCUS
LV left ventricular, LA left atrium, MV mitral valve, AV aortic valve, TV tricuspid valve, TEE transesophageal echocardiogram, RV right ventricle, TAPSE tricuspid annular 
plane systolic excursion, PHT pressure half-time, dTR pressure gradient measured in tricuspid regurgitation
Echocardiographic finding Prevalence (P) Impact (I) Difficulty (D) PxIxD Rank
LV hypertrophy 3 2 2 12 1
Rheumatic mitral disease (stenosis suggested by large LA) 2 2 3 12 1
Cardiomyopathy, severe 3 2 2 12 1
Cor pulmonale 2 2 3 12 1
Pericardial effusion 1 3 3 9 2
Regurgitation (MV, AV, TV by color Doppler) 2 2 2 8 3
Rheumatic mitral stenosis (valve morphology only) 2 2 1 4 4
Rheumatic aortic stenosis (valve morphology only) 2 2 1 2 4
Endocarditis (large vegetations seen on TTE) 1 2 2 4 4
RV function grading (e.g., TAPSE) 2 2 1 4 4
Mitral stenosis grading (PHT) 2 2 1 4 4
Aortic stenosis grading (continuation equation) 2 2 1 4 4
Regional hypokinesia 2 2 1 4 4
LV function grading (e.g., ejection fraction) 3 1 1 3 5
Endocarditis (TEE) 1 2 1 2 6
Endomyocardial fibrosis 1 1 2 2 6
Congenital heart diseases 1 2 1 2 6
Pulmonary artery pressure (dTR) 2 1 1 2 6
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and valvular causes were less common, but reported by 
most studies. Endomyocardial fibrosis, pericardial effu-
sion, cor pulmonale and congenital causes were only 
reported by a selected number of publications and their 
frequency was low.
The cardiac ultrasound in resource‑limited settings 
(CURLS) protocol
Based on the 5 highest ranking conditions (Table  3), 
we propose a protocol that focuses on the identifica-
tion of pericardial effusion, dilated cardiomyopathy, 
cor pulmonale, rheumatic mitral disease, and left ven-
tricular hypertrophy. The proposed protocol answers 5 
key questions summarized in Box 1. All 5 questions can 
be answered using a single subxiphoid view in B mode. 
More advanced sonographers have the option of addi-
tional views as outlined in Table 4 (Additional files 2, 3, 
4, 5, 6, 7).
Box 1: Cardiac ultrasound in resource‑limited settings 
(CURLS) protocol—5 questions
CURLS protocol: 5 questions Interpretation
1. Is a pericardial effusion present? Yes: consider cardiac tamponade
No: consider alternative cause of 
heart failure
2. Is the left ventricular function 
reduced?
Yes: consider cardiomyopathy of 
various causes
No: consider alternative cause of 
heart failure
3. Is the right ventricle larger than 
the left ventricle?
Yes: consider pulmonary artery 
hypertension or pulmonary 
embolism
No: consider alternative cause of 
heart failure
4. Is the left atrium larger than the 
left ventricle?
Yes: consider mitral stenosis or 
regurgitation, possibly caused by 
rheumatic heart disease
No: Consider alternative cause of 
heart failure
5. Is the left ventricle wall (septum) 
thicker than 12 mm?
Yes: consider hypertension, or aortic 
stenosis/regurgitation
No: consider alternative cause of 
heart failure
1. Is a pericardial effusion present?
Pericardial effusion is easily identified in a subxiphoid 
view and usually presents as an anechoic rim around 
the heart. If a significant pericardial effusion is present, 
the heart should be evaluated for signs of tamponade. 
If jugular veins are distended, the patient has tachycar-
dia and low blood pressure, obstructive shock and tam-
ponade may be present. Right atrial systolic collapse and 
right ventricle (RV) diastolic collapse suggest tamponade 
physiology. It is important to be aware that if the rate 
of fluid accumulation is rapid, even a small effusion can 
cause hemodynamic compromise. In a patient with car-
diac tamponade emergency pericardiocentesis can be 
life-saving. In resource-limited settings an ultrasound-
guided intercostal approach with a simple cannula can be 
used [37].
2. Is the left ventricular function reduced?
Dilated cardiomyopathy can have multiple causes, but 
sonographically, the end stage is similar with global 
enlargement of both atria and ventricles with reduced left 
ventricular systolic function. Unfortunately, most symp-
tomatic patients present in a late stage of the disease. For-
mal measurement of the ejection fraction and assessment 
of regional wall motion abnormalities is mostly confined 
to referral centers as it requires dedicated echocardio-
graphic software and substantial experience. However, 
a broad classification of left ventricular contractility as 
hyperdynamic, normal, moderately impaired and severely 
impaired, can be made by estimating whether contrac-
tion is symmetrical towards the center, whether the myo-
cardium thickens as it contracts, and whether the mitral 
valve opens normally during diastole. In an enlarged 
heart, this can usually be achieved in a subxiphoid view.
3. Is the right ventricle larger than the left ventricle?
An enlarged RV can indicate cor pulmonale. Cardiac 
ultrasound can demonstrate sonographic features of cor 
pulmonale by evaluating shape, size and pressure of the 
right side of the heart. In the subxiphoid view, in the 
presence of a normal-sized left ventricle (LV), the RV is 
typically 2/3 the size of the LV, any larger suggests RV 
enlargement. If the RV is equal in size to the LV, it is 
considered moderately enlarged. Pronounced dilatation 
of the RV such that it is larger than the LV is considered 
severe RV enlargement and cor pulmonale may be con-
sidered. In addition, movement of the intraventricular 
septum away from the RV indicates increased right ven-
tricular pressure or volume, resulting in a D-shaped LV 
in the parasternal short axis view (optional view). The 
measurement of RV contractility and the calculation of 
the pressure gradient in the setting of tricuspid regurgita-
tion can be helpful. However, this is technically more dif-
ficult and requires Doppler software, so it is best reserved 
for referral sites.
4. Is the left atrium larger than the left ventricle?
An enlarged left atrium (LA) is a feature of mitral steno-
sis and/or regurgitation, which may serve as a surrogate 
marker for RHD. The LA often becomes larger than the 
normal-sized LV by the time the patient presents. Addi-
tional findings include a thickened mitral valve with a 
diastolic hockey stick appearance or “doming” of the 
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valve leaflets. The right heart may also be enlarged due 
to the subsequent increase in pulmonary pressures. Post-
rheumatic changes of the aortic valve are slightly more 
difficult to detect as they initially lead to left ventricular 
hypertrophy only and the aortic valve is more difficult 
to visualize on ultrasound from a subxiphoid view. The 
morphological assessment of the aortic valve is possible 
at referral centers, as is the detection of mitral and aortic 
regurgitation if color-Doppler is available. For the basic 
CURLS exam, these questions were not included.
5. Is the left ventricle wall (septum) thicker than 12 mm?
Left ventricular hypertrophy can be determined by meas-
uring the intra-ventricular septum (IVS) at end diastole. 
The standard measurement of the IVS is performed in 
the parasternal long axis view and should be less than 
12  mm. Nevertheless, the septum is generally visible in 
the subxiphoid view. The clinician should freeze the 
screen and scroll back to end diastole where the IVS is 
measured at the level of the mitral valve leaflet tips.
Discussion
The clinical syndrome of heart failure is prevalent around 
the world. However, the underlying pathology differs sig-
nificantly between resource-limited and resource-affluent 
settings. Ischemic heart disease is the main underlying 
cause in high-resource settings, but is only observed in 
a minority of patients in SSA. On the other hand, dilated 
cardiomyopathy, RHD and pericarditis (mostly TB-
related) are important causes of heart failure in resource-
limited settings, which are less prevalent in high-resource 
settings. Limited cardiac ultrasound can play a significant 
role in differentiating between underlying causes. Based 
on our analysis of the frequency of cardiac conditions, 
the impact on treatment decisions and the ease of use, 
we identified five cardiac conditions relevant to SSA for 
the CURLS protocol. The protocol should serve in emer-
gency departments or acute patient settings and is not 
intended for screening asymptomatic patients.
Our literature search identified hypertension as the 
most common cause of heart failure followed by dilated 
cardiomyopathy and valvular causes. Pericardial effusion 
and cor pulmonale were less frequently reported, but 
play a significant role in sub-populations such as HIV-
infected patients. Our suggested “cardiac ultrasound for 
the resource-limited setting” (CURLS) protocol aims to 
identify these conditions in the “5-question” approach 
summarized in Box  1 and Table  4. The first question 
addresses pericardial effusion. Although less common 
then the other cardiac conditions, it is very easy to rec-
ognize and can have life-threatening implications when 
present. In African patients effusions that mimic con-
gestive heart failure are a common presenting sign of TB 
[38]. Tuberculosis is the most common cause of pericar-
ditis in Africa. In a South African study, TB pericarditis 
was responsible for 70% of all cases referred for diagnos-
tic pericardiocentesis and 96% of those who were HIV 
infected [39]. The second question assesses LV function 
as dilated cardiomyopathy was the second most com-
mon cause of heart failure in SSA in our literature review, 
accounting for approximately 20% of cases in most stud-
ies. Causative factors include myocarditis, HIV-asso-
ciated cardiomyopathy, alcohol, nutritional deficiency, 
thyrotoxicosis and pregnancy. In some areas, iron over-
load and other metabolic factors may play a role [40]. 
HIV-associated cardiomyopathy is reported in 9–57% of 
patients who are HIV-positive in Africa [41]. The third 
question focuses on RV size to detect cor pulmonale. 
While chronic obstructive pulmonary disease and pulmo-
nary hypertension secondary to left-sided heart failure are 
seen in all settings, chronic fibrocavitary TB is a frequent 
underlying cause in Africa [42]. In addition, HIV, schis-
tosomiasis, and pulmonary embolism can lead to chronic 
pulmonary hypertension eventually resulting in cor pul-
monale [43, 44]. Moreover, patients with HIV may suf-
fer from HIV-associated pulmonary artery hypertension. 
The fourth question considers left atrial size to assess 
for sequelae of mitral stenosis or mitral regurgitation. In 
contrast to high-resource settings, where valvular disease 
is largely degenerative in origin, in Africa valvular disease 
is almost invariably the result of infectious disease, either 
directly in infective endocarditis, or indirectly, following 
acute rheumatic disease [45]. Whereas degenerative val-
vular disease afflicts mainly the elderly, RHD is encoun-
tered in young, school-age children or young females of 
childbearing age. The course of RHD is more rapid than 
in degenerative disease and predisposes to cardiac failure, 
secondary endocarditis, atrial fibrillation and stroke [46]. 
Most patients with RHD have mixed mitral valve stenosis 
and regurgitation [47]. Aortic regurgitation is seen in less 
than 50% of the patients and it is found almost always in 
combination with mitral valve disease; aortic stenosis is 
rare [48]. Finally, the protocol addresses left ventricular 
hypertrophy, generally the result of uncontrolled hyper-
tension. The prevalence of hypertension is high in many 
African settings, and remains frequently undiagnosed 
and inadequately treated [49]. It is therefore a frequently 
identified etiology for cardiac failure in SSA [50].
Ultrasound protocols designed specifically for 
resource-limited settings have proven effective in SSA. 
Heller et al. demonstrated that the FASH (focused assess-
ment with sonography for HIV-associated tuberculo-
sis) exam could be efficiently taught to ultrasound-naïve 
clinicians over a 2-day training period [51]. The FASH 
exam has now become widely established as an impor-
tant ultrasound exam for clinicians working in African 
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settings with a high burden of HIV [52]. Similar success 
in ultrasound training has been demonstrated with the 
application of the 10-point yes/no checklist for various 
point-of-care ultrasound applications in a tertiary refer-
ral hospital in Tanzania [53]. Recently, a study in Kenya 
demonstrated the utility of a focused cardiac protocol 
applied in patient care by clinical officers [54]. Henwood 
et  al. also demonstrated that a longitudinal ultrasound 
training program could detect basic cardiac abnormali-
ties with high sensitivity and specificity when compared 
to experienced sonographer interpretation [55]. These 
studies suggest that implementation of a focused CURLS 
protocol is feasible.
Some limitations of the protocol should be high-
lighted. The protocol has not been validated in clinical 
practice, so its sensitivity and specificity still need to be 
determined. While the use of only the subxiphoid view 
simplifies the protocol for non-expert sonographers, it 
is possible that the image quality is insufficient in some 
patients. Furthermore, as with any focused protocol, it 
is not a replacement of an expert cardiology ultrasound 
and difficult cases should be referred for more extensive 
workup. Finally, no evidence is available that the protocol 
enhances diagnosis of cardiac pathologies in resource-
limited settings. Hence, the protocol we outline here is 
set forward as a research agenda and discussion point to 
encourage all providers to think about how the incredible 
potential of ultrasound can become more context spe-
cific for both patients and providers. Future studies need 
to assess if the CURLS protocol is trainable and whether 
significant cardiac findings are missed in comparison to 
“full specialist” echo exam even though this is not widely 
available.
Conclusions
Based on the epidemiology of heart disease in sub-Saha-
ran Africa and expert consensus on difficulty and impact 
of cardiac sonographic examinations, we propose a pro-
tocol for screening symptomatic patients with signs of 
heart failure and/or cardiomegaly on chest X-ray in 
resource-limited settings. This protocol is unique in that 
uses primarily the subxiphoid view and is designed to 
have high clinical relevance whilst being easy to use for 
providers at the front line of patient care in these settings. 
The protocol assesses pericardial effusion, dilated cardio-
myopathy, cor pulmonale, mitral valve disease, and left 
ventricular hypertrophy. The protocol has great poten-
tial to influence treatment of patients with heart failure 
in resource-limited settings. Future studies are needed to 
evaluate whether the protocol can easily be taught and 
implemented by clinicians, and if ultrasound findings 
have a positive influence on treatment decisions without 
missing important findings that would be observed by a 
specialist echocardiogram.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1308 9‑019‑0149‑0.
Additional file 1: Figure S1. Literature search flowchart. Table S1. 
Baseline characteristics of included studies on etiologies of cardiac disease 
in SSA (2008–2018).
Additional file 2. Normal heart.
Additional file 3. Pericardial effusion.
Additional file 4. Dilated cardiomyopathy.
Additional file 5. Right sided heart failure.
Additional file 6. Rheumatic heart disease with mitral valve dysfunction.
Additional file 7. Left ventricular hypertrophy.
Abbreviations
AV: aortic valve; CMP: cardiomyopathy; CURLS: cardiac ultrasound for resource‑
limited settings; cw: continuous wave; dTR: pressure gradient measured 
in tricuspid regurgitation; FASH: focused assessment with sonography for 
HIV‑associated tuberculosis; HF: heart failure; HIV: human immunodeficiency 
virus; LA: left atrium; LV: left ventricle; MV: mitral valve; PHT: pressure half‑time; 
POCUS: point‑of‑care ultrasound; RHD: rheumatic heart disease; RV: right 
ventricle; SSA: sub‑Saharan Africa; TAPSE: tricuspid annular plane systolic 
excursion; TB: tuberculosis; TEE: transesophageal echocardiography; TV: tricus‑
pid valve; US: ultrasound.
Acknowledgements
Not applicable.
Authors’ contributions
TH, DKam conceived the idea of cardiac protocol while teaching ultrasound 
in various geographic settings, MH conducted the literature review for 
prevalence, TH, DKam, MH, VK and BK assessed the difficulty of teaching, CW, 
PG and DKah assessed the relevance with respect to treatment, MH and TH 
drafted the first manuscript, SB, DKah, Dkam, PG, VK, BK and SP commented 
extensively on the drafts. All authors read and approved the final manuscript.
Funding
No funding was received for writing this manuscript. SB is currently a partici‑
pant in the BIH‑Charité Clinician Scientist Program funded by Charité–Univer‑
sitätsmedizin Berlin and the Berlin Institute of Health.
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated or 
analyzed during the current study.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Department of Microbiology and Infectious Diseases, Erasmus Medical 
Centre, Rotterdam, The Netherlands. 2 Department of Emergency Medicine, 
Medical College of Georgia, Augusta University, Augusta, GA, USA. 3 Depart‑
ment of Internal Medicine, University of California, Los Angeles, CA, USA. 
4 Department of Paediatric Pulmonology, Immunology and Intensive Care 
Medicine, Charité–Universitätsmedizin Berlin, Berlin, Germany. 5 Berlin Institute 
of Health, Berlin, Germany. 6 Lighthouse Clinic, Kamuzu Central Hospital, 
Page 9 of 10Huson et al. Ultrasound J           (2019) 11:34 
Lilongwe, Malawi. 7 International Training and Education Centre for Health, 
University of Washington, Seattle, WA, USA. 8 Department of Internal Medicine, 
College of Medicine, University of Malawi, Blantyre, Malawi. 9 Division of Infec‑
tious Diseases and Tropical Medicine, University Hospital, LMU, Munich, Ger‑
many. 10 Department of Global Health, University of Washington, Seattle, USA. 
11 Department of Medicine, University of North Carolina School of Medicine, 
Chapel Hill, NC, USA. 12 Department of Public Health, College of Medicine, 
School of Public Health and Family Medicine, University of Malawi, Lilongwe, 
Malawi. 13 Department of Tropical Medicine, Bernhard Nocht Institute 
for Tropical Medicine, I. Department of Medicine, University Medical Center 
Hamburg‑Eppendorf, Hamburg, Germany. 
Received: 21 May 2019   Accepted: 16 December 2019
References
 1. Mensah GA, Roth GA, Sampson UK, Moran AE, Feigin VL, Forouzanfar 
MH et al (2015) Mortality from cardiovascular diseases in sub‑Saharan 
Africa, 1990–2013: a systematic analysis of data from the Global Burden of 
Disease Study 2013. Cardiovasc J Afr. 26(2 Suppl 1):S6–S10
 2. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A et al 
(2008) Spectrum of heart disease and risk factors in a black urban popula‑
tion in South Africa (the Heart of Soweto Study): a cohort study. Lancet 
371(9616):915–922
 3. Sliwa K (2016) The heart of Africa: succeeding against the odds. Lancet 
388(10063):e28–e36
 4. Sliwa K (2013) Is all heart failure the same around the globe? Eur Heart J 
34(40):3091–3092
 5. Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A et al (2017) Global 
mortality variations in patients with heart failure: results from the Inter‑
national Congestive Heart Failure (INTER‑CHF) prospective cohort study. 
Lancet Glob Health. 5(7):e665–e672
 6. Makubi A, Hage C, Sartipy U, Lwakatare J, Janabi M, Kisenge P et al (2016) 
Heart failure in Tanzania and Sweden: Comparative characterization and 
prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish 
Heart Failure Registry (SwedeHF). Int J Cardiol 220:750–758
 7. Heller T, Mtemang’ombe EA, Huson MA, Heuvelings CC, Bélard S, Janssen 
S et al (2017) Ultrasound for patients in a high HIV/tuberculosis preva‑
lence setting: a needs assessment and review of focused applications for 
Sub‑Saharan Africa. Int J Infect Dis. 56:229–236
 8. Mayosi BM (2007) Contemporary trends in the epidemiology and man‑
agement of cardiomyopathy and pericarditis in sub‑Saharan Africa. Heart 
93(10):1176–1183
 9. Beaton A, Lu JC, Aliku T, Dean P, Gaur L, Weinberg J et al (2015) The utility 
of handheld echocardiography for early rheumatic heart disease diagno‑
sis: a field study. Eur Heart J Cardiovasc Imaging. 16(5):475–482
 10. Ploutz M, Lu JC, Scheel J, Webb C, Ensing GJ, Aliku T et al (2016) Handheld 
echocardiographic screening for rheumatic heart disease by non‑experts. 
Heart 102(1):35–39
 11. Sims Sanyahumbi A, Sable CA, Karlsten M, Hosseinipour MC, Kazembe 
PN, Minard CG et al (2017) Task shifting to clinical officer‑led echocardiog‑
raphy screening for detecting rheumatic heart disease in Malawi, Africa. 
Cardiol Young 27(6):1133–1139
 12. Barasa E, Rogo K, Mwaura N, Chuma J (2018) Kenya National Hospital 
Insurance Fund Reforms: implications and lessons for universal health 
coverage. Health Syst Reform 4:346–361
 13. Nelson BP, Sanghvi A (2013) Point‑of‑care cardiac ultrasound: feasibility of 
performance by noncardiologists. Glob Heart 8(4):293–297
 14. Beaton A, Aliku T, Okello E, Lubega S, McCarter R, Lwabi P et al (2014) The 
utility of handheld echocardiography for early diagnosis of rheumatic 
heart disease. J Am Soc Echocardiogr 27(1):42–49
 15. Lu JC, Sable C, Ensing GJ, Webb C, Scheel J, Aliku T et al (2015) Simplified 
rheumatic heart disease screening criteria for handheld echocardiogra‑
phy. J Am Soc Echocardiogr 28(4):463–469
 16. Becker TK, Tafoya CA, Osei‑Ampofo M, Tafoya MJ, Kessler RA, Theyyunni N 
et al (2017) Cardiopulmonary ultrasound for critically ill adults improves 
diagnostic accuracy in a resource‑limited setting: the AFRICA trial. Trop 
Med Int Health 22(12):1599–1608
 17. Bedeker WF, Lachman AS, Borkum M, Hellenberg D, Cupido CS (2015) 
Impact of transthoracic echocardiography at district hospital level. S Afr 
Med J 105(10):817–822
 18. Kwan GF, Bukhman AK, Miller AC, Ngoga G, Mucumbitsi J, Bavuma C et al 
(2013) A simplified echocardiographic strategy for heart failure diagnosis 
and management within an integrated noncommunicable disease 
clinic at district hospital level for sub‑Saharan Africa. JACC Heart Fail. 
1(3):230–236
 19. van Hoving DJ, Lamprecht HH, Stander M, Vallabh K, Fredericks D, Louw 
P et al (2013) Adequacy of the emergency point‑of‑care ultrasound core 
curriculum for the local burden of disease in South Africa. Emerg Med J. 
30(4):312–315
 20. Appiah LT, Sarfo FS, Agyemang C, Tweneboah HO, Appiah NABA, 
Bedu‑Addo G et al (2017) Current trends in admissions and outcomes of 
cardiac diseases in Ghana. Clin Cardiol 40(10):783–788
 21. Bonsu KO, Owusu IK, Buabeng KO, Reidpath DD, Kadirvelu A (2017) Clini‑
cal characteristics and prognosis of patients admitted for heart failure: a 
5‑year retrospective study of African patients. Int J Cardiol 238:128–135
 22. Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D et al (2012) 
The causes, treatment, and outcome of acute heart failure in 1006 Afri‑
cans from 9 countries. Arch Intern Med 172(18):1386–1394
 23. Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A et al (2016) Heart 
failure in Africa, Asia, the Middle East and South America: The INTER‑CHF 
study. Int J Cardiol 204:133–141
 24. Makubi A, Hage C, Lwakatare J, Kisenge P, Makani J, Ryden L et al (2014) 
Contemporary aetiology, clinical characteristics and prognosis of adults 
with heart failure observed in a tertiary hospital in Tanzania: the prospec‑
tive Tanzania Heart Failure (TaHeF) study. Heart 100(16):1235–1241
 25. Mwita JC, Dewhurst MJ, Magafu MG, Goepamang M, Omech B, Majuta KL 
et al (2017) Presentation and mortality of patients hospitalised with acute 
heart failure in Botswana. Cardiovasc J Afr 28(2):112–117
 26. Nkoke C, Makoge C, Dzudie A, Mfeukeu LK, Luchuo EB, Menanga A et al 
(2017) A predominance of hypertensive heart disease among patients 
with cardiac disease in Buea, a semi‑urban setting, South West Region of 
Cameroon. BMC Res Notes 10(1):684
 27. Ojji D, Stewart S, Ajayi S, Manmak M, Sliwa K (2013) A predominance of 
hypertensive heart failure in the Abuja Heart Study cohort of urban Nige‑
rians: a prospective clinical registry of 1515 de novo cases. Eur J Heart Fail 
15(8):835–842
 28. Pio M, Afassinou Y, Pessinaba S, Baragou S, N’Djao J, Atta B et al (2014) 
Epidemiology and etiology of heart failure in Lome. Pan Afr Med J 18:183
 29. Ansa V, Otu A, Oku A, Njideoffor U, Nworah C, Odigwe C (2016) Patient 
outcomes following after‑hours and weekend admissions for cardiovas‑
cular disease in a tertiary hospital in Calabar, Nigeria. Cardiovasc J Afr 
27(5):328–332
 30. Boombhi J, Moampea M, Kuate L, Menanga A, Hamadou B, Kingue S 
(2017) Clinical pattern and outcome of acute heart failure at the Yaounde 
Central Hospital. Open Access Lib J 4:1
 31. Kingery JR, Yango M, Wajanga B, Kalokola F, Brejt J, Kataraihya J et al 
(2017) Heart failure, post‑hospital mortality and renal function in Tanza‑
nia: a prospective cohort study. Int J Cardiol 243:311–317
 32. Massoure PL, Roche NC, Lamblin G, Topin F, Dehan C, Kaiser E et al (2013) 
Heart failure patterns in Djibouti: epidemiologic transition. Med Sante 
Trop 23(2):211–216
 33. Ogah OS, Stewart S, Falase AO, Akinyemi JO, Adegbite GD, Alabi AA et al 
(2014) Contemporary profile of acute heart failure in Southern Nigeria: 
data from the Abeokuta Heart Failure Clinical Registry. JACC Heart Fail 
2(3):250–259
 34. Ogah OS, Adegbite GD, Akinyemi RO, Adesina JO, Alabi AA, Udofia OI et al 
(2008) Spectrum of heart diseases in a new cardiac service in Nigeria: an 
echocardiographic study of 1441 subjects in Abeokuta. BMC Res Notes 
1:98
 35. Onwuchekwa AC, Asekomeh GE (2009) Pattern of heart failure in a Nige‑
rian teaching hospital. Vasc Health Risk Manag 5:745–750
 36. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J 
et al (2008) Predominance of heart failure in the Heart of Soweto Study 
cohort: emerging challenges for urban African communities. Circulation 
118(23):2360–2367
 37. Heller T, Lessells RJ, Wallrauch C, Brunetti E (2010) Tuberculosis pericarditis 
with cardiac tamponade: management in the resource‑limited setting. 
Am J Trop Med Hyg 83(6):1311–1314
Page 10 of 10Huson et al. Ultrasound J           (2019) 11:34 
 38. Desai HN (1979) Tuberculous pericarditis. A review of 100 cases. S Afr Med 
J 55(22):877–880
 39. Reuter H, Burgess LJ, Doubell AF (2005) Epidemiology of pericardial 
effusions at a large academic hospital in South Africa. Epidemiol Infect 
133(3):393–399
 40. Sliwa K, Damasceno A, Mayosi BM (2005) Epidemiology and etiology of 
cardiomyopathy in Africa. Circulation 112(23):3577–3583
 41. Ntsekhe M, Hakim J (2005) Impact of human immunodeficiency 
virus infection on cardiovascular disease in Africa. Circulation 
112(23):3602–3607
 42. Aderaye G (2004) Causes and clinical characteristics of chronic cor‑
pulmonale in Ethiopia. East Afr Med J 81(4):202–206
 43. Klein SK, Slim EJ, de Kruif MD, Keller TT, ten Cate H, van Gorp EC et al 
(2005) Is chronic HIV infection associated with venous thrombotic dis‑
ease? A systematic review. Neth J Med 63(4):129–136
 44. Ramlakhan R, Andronikou S, Rajkumar A (2017) The prevalence and radio‑
logical findings of pulmonary embolism in HIV‑positive patients referred 
for computed tomography pulmonary angiography in the Western Cape 
of South Africa. Cardiovasc J Afr 28(4):221–228
 45. Strasser T (1980) Community control of rheumatic heart disease in 
developing countries: 1 a major public health problem. WHO Chron 
34(9):336–345
 46. Essop M, Nkomo V (2005) Rheumatic and nonrheumatic valvular heart 
disease: epidemiology, management, and prevention in Africa. Circula‑
tion 112(23):3584–3591
 47. Malla R, Thapaliya S, Gurung P, Bogati A, Khadka S, Shrestha S et al (2016) 
Patterns of Valvular Involvement in Rheumatic Heart Disease patients 
taking Benzathine Penicillin at Shahid Gangalal National Heart Centre, 
Kathmandu, Nepal. Nepal Heart J 13(2):25–27
 48. Faheem M, Hafizullah M, Gul A, Ullah Jan H, Asghar Khan M. Pattern 
of valvular lesions in rheumatic heart disease. J Postgrad Med Inst. 
2007;21(2):99–103
 49. Addo J, Smeeth L, Leon DA (2007) Hypertension in sub‑saharan Africa: a 
systematic review. Hypertension 50(6):1012–1018
 50. Amoah AG, Kallen C (2000) Aetiology of heart failure as seen from a 
National Cardiac Referral Centre in Africa. Cardiology 93(1–2):11–18
 51. Heller T, Wallrauch C, Lessells RJ, Goblirsch S, Brunetti E (2010) Short 
course for focused assessment with sonography for human immunode‑
ficiency virus/tuberculosis: preliminary results in a rural setting in South 
Africa with high prevalence of human immunodeficiency virus and 
tuberculosis. Am J Trop Med Hyg 82(3):512–515
 52. Salmon M, Landes M, Hunchak C, Paluku J, Malemo Kalisya L, Salmon 
C et al (2017) Getting it right the first time: defining regionally relevant 
training curricula and provider core competencies for point‑of‑care 
ultrasound education on the african continent. Ann Emerg Med 
69(2):218–226
 53. Stanley A, Wajanga BM, Jaka H, Purcell R, Byrne L, Williams F et al (2017) 
The impact of systematic point‑of‑care ultrasound on management of 
patients in a resource‑limited setting. Am J Trop Med Hyg 96(2):488–492
 54. Barasa FB, DeLong A, Kimaiyo S, Koech M, Binanay C, Foster M et al (2018) 
Diagnostic accuracy of focused cardiac ultrasound for common cardiac 
conditions in a Kenyan hospital. J Kenya Assoc Phys 1(1):5–13
 55. Henwood PC, Mackenzie DC, Liteplo AS, Rempell JS, Murray AF, Leo MM 
et al (2017) Point‑of‑care ultrasound use, accuracy, and impact on clinical 
decision making in rwanda hospitals. J Ultrasound Med 36(6):1189–1194
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
